CDC has just announced they will revoke the emergency use authorization of the RT-PCR tests first introduced in 2/20. “CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS CoV-2 and influenza viruses.”
CDC Quietly Revokes RT-PCR Emergency Use Authorization Because They Counted Covid-19 and Influenza Together https://t.co/qwj5dnmYxN. No wonder there was no flu— Joe Bastardi (@BigJoeBastardi) July 27, 2021
To be clear, this is not a new development. These assays have been known for years to be unable to distinguish between the different types of coronaviruses, but they ran with it anyway. According to the CDC website [emphasis added]:
After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.
In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test. CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses. Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season. Laboratories and testing sites should validate and verify their selected assay within their facility before beginning clinical testing.
Why the sudden change?
The RT-PCR assays could detect the presence of a coronavirus from a swab in real-time, making it a good indicator of the potential for Covid-19 infection. In a sane world that wasn’t driven by a nefarious agenda, positive results on the RT-PCR tests would have been treated as indicators that someone needed to get a real test, like an antigen test, to determine if they were infected. But this isn’t a sane world and the powers-that-be saw an opportunity to bump up numbers to drive panic. They ran with it, and revoking the EUA means they’re done with that particular type of fearmongering. The RT-PCR assays served their purpose.
The other reason for this move is very concerning. This shift and its timing both indicate the powers-that-be are anticipating a need to differentiate between the various coronaviruses. If it really is the need to differentiate Covid-19 and influenza as they’re claiming, then that jibes with the sudden push to maximize or even mandate flu vaccines within months. If that’s the scenario they have planned, expect a sudden surge in flu cases after a year where they “miraculously” disappeared thanks to RT-PCR tests claiming everything was Covid-19.
So we have to ask why is it that it’s important to separate them NOW? What fresh variant is headed our way? What infringements on our liberty do they have in mind? How are they going to gin up fear for a disease that only affects co-morbidities, and even then has an almost 100% recovery rate?
First, stop listening to the bots on social media. Second, follow us for more updates.